WST Stock Analysis: Buy, Sell, or Hold?
WST - West Pharmaceutical Services, Inc.
$231.12
-1.53 (-0.66%)
▼
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 12, 2026
11d
Get Alerted When WST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: WST trading at deep discount. Market pricing in -4.3% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: WST trading at deep discount. Market pricing in -4.3% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$267.27
Based on 6.7% avg growth
INTRINSIC VALUE TODAY
$165.95
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: WST is currently trading at $231.12, which is considered oversold relative to its 30-day fair value range of $246.94 to $280.96. From a valuation perspective, the stock is trading at a discount (Forward PE: 30.0) compared to its historical average (34.2). Remarkably, the market is currently pricing in an annual earnings decline of 4.3% over the next few years. This pessimistic expectation contrasts with the company's recent 3.8% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, WST is showing sideways momentum. Immediate support is located at $223.83, while resistance sits at $279.39.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $345.71 (+48.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, WST is showing sideways momentum. Immediate support is located at $223.83, while resistance sits at $279.39.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $345.71 (+48.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$246.94 -
$280.96
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 48.6% below Wall St target ($345.71)
Fair Price Analysis
30-Day Fair Range
$246.94 -
$280.96
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$223.83
Resistance Level
$279.39
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
30.00
Wall Street Target
$345.71
(+48.6%)
Revenue Growth (YoY)
7.7%
Earnings Growth (YoY)
3.8%
Profit Margin
16.3%
Valuation Discount vs History
-4.3% cheaper
PE vs Historical
30.0 vs 34.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.3%
(market-implied from PE analysis)
1-Year Target
$222.65
(-4%)
2-Year Target
$213.07
(-8%)
3-Year Target
$203.91
(-12%)
3-Yr Target (if PE normalizes)
(PE: 30→34)
$232.44
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 30.0, Growth: 9.3%)
$303.43
(+30%)
Base:
(SPY PE: 22.3, Growth: 9.3%)
$225.53
(-3%)
Bear:
(PE: 19.0, Growth: 9.3%)
$191.70
(-18%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (35x PE), but valuation improves significantly next year (30x PE) as earnings recover.
Trailing PE: 34.95 | Current EPS (TTM): $6.75
Bull Case
$298.09
(+29%)
Analyst growth 14.9%, PE expands to 38.4
Base Case
$270.99
(+17%)
Market implied 14.9%, PE stable at 35.0
Bear Case
$160.41
(-31%)
Severe decline -20.0%, PE contracts to 29.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 30.0 to 34.2
Stabilization Target:
$265.20
(+14.0%)
PE Expansion Potential:
+14.0%
Last updated: January 31, 2026 6:47 AM ET
Data refreshes hourly during market hours. Next update: 7:47 AM
Data refreshes hourly during market hours. Next update: 7:47 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is WST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$92 | 63 BUY |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$608 | 58 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$191 | 58 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$292 | 57 HOLD |
|
ALGN
Align Technology Inc |
BUY
18 analysts |
$184 | 62 BUY |
Advanced WST Option Strategies
Professional options setups generated by AI based on today's WST price and gamma walls.
